Demonstrates improved wound closure in vitro using a novel kombucha-derived scaffold, indicating strong potential for biomedical use.
Bacterial cellulose derived from coffee kombucha (KBC) is a renewable, biocompatible biopolymer; however, its limited intrinsic antimicrobial activity limits its biomedical applications. In this study, a sustainable and integrated biosynthetic approach was used to develop chitosan-reinforced, silver nanoparticle-decorated kombucha bacterial cellulose nanocomposite (KCBC-Ag). Silver nanoparticles (Ag NPs) biosynthesized by the coffee kombucha consortium had an average diameter of approximately 50 nm and were uniformly distributed within the cellulose matrix. The KBC-Ag exhibited potent antibacterial activity against Escherichia coli and Staphylococcus aureus , demonstrated high cytocompatibility toward HaCaT cells, and significantly improved wound closure in scratch assay (approximately 98% after 24 h). Additionally, the scaffold displayed favorable swelling properties and environmental degradability. These results indicate that KBC-Ag is a promising, sustainably fabricated wound dressing material that integrates biocompatibility, antibacterial performance, and regenerative capacity, with potential for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Candra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: